Zeo ScientifiX (ZEOX) Shares Outstanding (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Shares Outstanding (Entity) of $7.8 million for Q2 2026, up 22.74% year-over-year from $6.3 million in Q2 2025, and up 2.27% quarter-over-quarter from $7.6 million in Q1 2026.
Zeo ScientifiX (ZEOX) Shares Outstanding (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Shares Outstanding (Entity) history runs 15 years deep, the most recent figure standing at $7.8 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 22.74% year-over-year to $7.8 million; the TTM figure through Apr 2026 stood at $7.8 million (up 22.74% YoY), while the FY2025 annual figure was $6.7 million, up 6.35% from the prior year.
- Shares Outstanding (Entity) for Q2 2026 stood at $7.8 million, up from $7.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $1.5 billion in Q2 2023, with the low at $6.1 million in Q1 2024.
- The 5-year median for Shares Outstanding (Entity) is $7.4 million (2023), against an average of $509.4 million.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) advanced 29.55% in 2023, then sank 99.59% in 2024.
- Zeo ScientifiX's Shares Outstanding (Entity) stood at $1.1 billion in 2022, then tumbled by 99.36% to $7.3 million in 2023, then retreated by 12.89% to $6.3 million in 2024, then gained by 6.35% to $6.7 million in 2025, then gained by 15.41% to $7.8 million in 2026.
- Business Quant data shows ZEOX's Shares Outstanding (Entity) at $7.8 million in Q2 2026, $7.6 million in Q1 2026, and $6.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 7.76 Mn |
| Jan 31, 2026 | 7.02 Mn |
| Oct 31, 2025 | 6.41 Mn |
| Jul 31, 2025 | 6.41 Mn |
| Apr 30, 2025 | 6.34 Mn |
| Jan 31, 2025 | 6.34 Mn |
| Oct 31, 2024 | 6.34 Mn |
| Jul 31, 2024 | 6.26 Mn |
| Apr 30, 2024 | 6.17 Mn |
| Jan 31, 2024 | 6.19 Mn |
| Oct 31, 2023 | 7.03 Mn |
| Jul 31, 2023 | 1.42 Bn |
| Apr 30, 2023 | 1.45 Bn |
| Jan 31, 2023 | 1.40 Bn |
| Oct 31, 2022 | 1.14 Bn |
| Jul 31, 2022 | 1.09 Bn |
| Apr 30, 2022 | 1.08 Bn |
| Jan 31, 2022 | 1.06 Bn |
| Oct 31, 2021 | 1.06 Bn |
| Jul 31, 2021 | 1.10 Bn |